Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (37)
  • 2024 (40)
  • 2023 (73)
  • 2022 (54)
  • 2021 (32)
  • 2020 (8)
  • 2019 (2)

Subject

  • Drug Trafficking (4010)
  • Synthetic drugs (1064)
  • Guns/Weapons (989)
  • OCDETF/Task Force (810)
  • Fake Pills (654)
  • Arrests/Convictions - Major (603)
  • Guilty Plea (529)
  • Seizures (Drugs/Property) (456)
  • Prescription Drugs (364)
  • Overdose (321)
  • Major Law Enforcement Operation (267)
  • Take Back Day (246)
  • Task Forces/Task Force Officers (230)
  • Pharmaceuticals/Pharmacists/Physicians (224)
  • Money Laundering (203)
  • Gangs (196)
  • Outreach/Drug Prevention (184)
  • Fentanyl Awareness (152)
  • One Pill Can Kill (110)
  • HIDTA (103)
  • Press Conferences (68)
  • Narcoterrorism (53)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (50)
  • Public and Media Affairs - also see Congressional Affairs (50)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Fentanyl Free America (12)
  • Intergovernmental Affairs (9)
  • Other (8)
  • Campaigns (7)
  • Critical Incident (6)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Diversion Division (242)
  • Counterfeit Pills (5)

Drug Name

  • Opioids (42)
  • Oxycodone (37)
  • Fentanyl (28)
  • Hydromorphone (13)
  • Synthetic Opioids (10)
  • Benzodiazepines (7)
  • Methamphetamine (6)
  • Morphine (6)
  • Amphetamines (3)
  • Methadone (3)
  • Steroids (3)
  • Cocaine (2)
  • Heroin (2)
  • Marijuana (Cannabis) (2)
  • Ketamine (1)
  • Marijuana Concentrates (1)

Field Division

  • Washington, DC (34)
  • New England (33)
  • New York (23)
  • Seattle (22)
  • Chicago (18)
  • Houston (15)
  • New Jersey (14)
  • Atlanta (13)
  • Miami (9)
  • New Orleans (8)
  • Sede (8)
  • St. Louis (8)
  • San Francisco (7)
  • Dallas (6)
  • El Paso (6)
  • Rocky Mountain (5)
  • Omaha (4)
  • Los Angeles (3)
  • Phoenix (3)
  • San Diego (3)
  • Detroit (2)
  • Louisville (2)
Clear All Results
PRESS RELEASE

Pharmacy Agrees to Pay $250,000 for Improperly Distributing Prescriptions

Septiembre 14, 2023
KANSAS CITY, Kan. - A Kansas City, Kansas, company entered into a civil settlement agreement with the federal government to pay $250,000 to resolve allegations that a retail pharmacy it owns violated the civil provisions of the Controlled Substances Act. Four B. Corporation, doing business as Balls Food Stores, owns...
Septiembre 14, 2023
PRESS RELEASE

Pharmacist Convicted for Conspiring to Unlawfully Dispense Over 100,000 Opioid Pills

Septiembre 14, 2023
Houston, TX. – A federal jury in Houston convicted a Texas pharmacist yesterday for her role in a pill-mill pharmacy that unlawfully dispensed over 100,000 opioid pills in exchange for cash. According to court documents and evidence presented at trial, from January 2014 to January 2018, Deanna Winfield-Gates, 54, of...
Septiembre 14, 2023
PRESS RELEASE

Illinois Man Sentenced to 30 Months for Theft of Medical Products and Possession of a Controlled Substance with Intent to Distribute

Septiembre 13, 2023
SPRINGFIELD, Ill. – Todd C. Smith, Assistant Special Agent in Charge at U.S. Drug Enforcement Administration Chicago Field Division, and U.S. Attorney Gregory K. Harris for the Central District of Illinois announced that Issac Jackson, 29, of Le Roy, Illinois, was sentenced on Sept. 7, 2023, to 30 months in...
Septiembre 13, 2023
PRESS RELEASE

Health Care Company and Cheshire Pharmacy Pay $500K to Resolve Controlled Substances Act Allegations

Agosto 31, 2023
CHESHIRE, Conn. - Vanessa Roberts Avery, United States Attorney for the District of Connecticut, Brian D. Boyle, Special Agent in Charge of the Drug Enforcement Administration for New England, announced that Clarest, LLC, doing business as Clarest Health, ProCare LTC New England LTC, and ProCare LTC Pharmacy of Connecticut LLC...
Agosto 31, 2023
PRESS RELEASE

Former Auburn Physician Pays $135,000 and Forfeits DEA Registration, for Overprescribing Controlled Substances

Agosto 30, 2023
SYRACUSE, NEW YORK – Dr. Jang Boo Chi, formerly a physician in Auburn, and his medical practice, Jang Boo Chi M.D. P.C., have agreed to pay the United States $135,000 in civil penalties for overprescribing opioids and other controlled substances in dangerous combinations. United States Attorney Carla B. Freedman, and...
Agosto 30, 2023
PRESS RELEASE

Austin Pharmacy to Pay $200,000 in Civil Penalties for Alleged Violations of the Controlled Substances Act

Agosto 17, 2023
AUSTIN, Texas – People’s Pharmacy Inc. has agreed to pay $200,000 in civil penalties to resolve allegations that it violated provisions of the Controlled Substances Act (CSA). People’s Pharmacy Inc., doing business as Peoples Rx, operates five retail pharmacies and one compounding laboratory in the Austin area. During a routine...
Agosto 17, 2023
PRESS RELEASE

Nurse Practitioner Pleads Guilty to Unlawful Drug Distribution

Agosto 11, 2023
ALBANY, NEW YORK – Danielle Simonson, age 51, of Fort Ann, New York, pled guilty today to distributing controlled substances outside the course of professional practice and for no legitimate medical purpose. The announcement was made by United States Attorney Carla B. Freedman; Special Agent in Charge Frank A. Tarentino...
Agosto 11, 2023
PRESS RELEASE

CA Attorney General Bonta Announces Arrest of Santa Clara Doctor for Illegal Opioid Prescription Scheme

Agosto 11, 2023
SANTA CLARA, Calif. — California Attorney General Rob Bonta today announced the arrest of and filing of charges against Dr. Arash Padidar, a Santa Clara County doctor accused of illegally prescribing opioids to patients. The arrest and charges are the result of an investigation into an alleged two-years-long illegal prescription...
Agosto 11, 2023
PRESS RELEASE

DEA Hosts Public Listening Sessions on Telemedicine Regulations

Agosto 07, 2023
WASHINGTON – The Drug Enforcement Administration will host public listening sessions to receive comments from healthcare practitioners, experts, advocates, patients, and other members of the public to inform DEA’s regulations on prescribing controlled substances via telemedicine. The listening sessions will be held in person and livestreamed with remote participation available...
Agosto 07, 2023
PRESS RELEASE

Physician Assistant at Chicago Medical Practice Charged with Fraudulently Writing Opioid Prescriptions

Agosto 04, 2023
CHICAGO — Sheila G. Lyons, Special Agent in Charge of U.S. Drug Enforcement Administration Chicago Field Division, and Acting U.S. Attorney Morris Pasqual for the Northern District of Illinois announced that a physician assistant who formerly worked at a Chicago medical practice has been charged in federal court with fraudulently...
Agosto 04, 2023
Showing 101 - 110 of 246 results

Paginación

  • Primera página «
  • Página anterior ‹
  • Página 7
  • Página 8
  • Página 9
  • Página 10
  • Current page 11
  • Página 12
  • Página 13
  • Página 14
  • Página 15
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster